Seller record · Telehealth service

Medsol RX

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the packages page, the product pages, the answers or the terms.

At a glance

Medsol RXTelehealth service

7/8criteria passed
Price
Semaglutide $169 the first month, then $199 a month; tirzepatide $239, then $259
Sells
compounded semaglutide injections, compounded tirzepatide injections, and 12 more
FDA letters
None on file
Visit Medsol RXSee all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A Florida telehealth weight loss clinic serving patients nationwide, selling compounded semaglutide and tirzepatide injections, oral semaglutide, microdose plans and branded Ozempic and Zepbound pens with care coaching, plus sermorelin, NAD+ and other wellness injections. Care starts with an online assessment and a telehealth consultation with an outside clinician network, and its terms name four partner pharmacies with street addresses.

Operating entity No legal entity name appears in the footer, in the terms and conditions, in the privacy policy or in the subscription and refund policy, which name the company only as Medsol RX.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSMedsol RX's website; Medsol RX's FAQ
S2Prescription gatingPASSMedsol RX's website; Medsol RX's subscription services cancellation and refund policy
S3Pharmacy identificationPASSMedsol RX's terms and conditions
S4Compounding disclosurePASSMedsol RX's website; Medsol RX's FAQ
S5Analytical documentationFAILMedsol RX's packages page; Medsol RX's FAQ; Medsol RX's terms and conditions
S6Business addressPASSMedsol RX's privacy policy; Medsol RX's terms and conditions
S7Price disclosurePASSMedsol RX's packages page; Medsol RX's semaglutide page; Medsol RX's tirzepatide page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe footer of every page says final prescribing decisions are made by licensed U.S. clinicians of the OpenLoop network after a telehealth consultation and a review of the medical history, and the answers say the medical team reviews every medication and supplement before prescribing.Source: Medsol RX's website; Medsol RX's FAQ.
S2PASSThe start buttons point to an online GLP-1 assessment that the footer says determines initial eligibility, followed by a telehealth consultation before any prescription. The subscription policy says membership begins once the intake form is completed and the first month is paid, with a full refund if the provider disqualifies the patient.Source: Medsol RX's website; Medsol RX's subscription services cancellation and refund policy.
S3PASSThe terms and conditions list four partner pharmacies with street addresses: Red Rock Compounding Pharmacy at 1240 East 100 South, Suite 220, St. George, Utah; HealthWarehouse at 7107 Industrial Rd., Florence, Kentucky; Precision Medicine at 2657 Merrick Road, Bellmore, New York; and Triad Rx at 26258 Pollard Road, Daphne, Alabama.Source: Medsol RX's terms and conditions.
S4PASSThe footer of every page states that compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or quality. The answers add that compounded GLP-1s contain the same active ingredients as the branded drugs and are prepared to the same clinical standards.Source: Medsol RX's website; Medsol RX's FAQ.
S5FAILNo certificate of analysis or lot document is published on the packages page, the product pages, the answers or the terms.Source: Medsol RX's packages page; Medsol RX's FAQ; Medsol RX's terms and conditions.
S6PASSMedsol RX at 660 W Flagler Street, Suite 900, Miami, FL 33130, printed as the company's location in the privacy policy. The terms say the company is headquartered in Florida and name Florida law.Source: Medsol RX's privacy policy; Medsol RX's terms and conditions.
S7PASSMonth to month, compounded semaglutide costs $169 the first month and then $199 a month, and compounded tirzepatide $239 the first month and then $259. On plans billed up front, semaglutide costs $169, $149 or $129 a month for 3, 6 or 12 months, billed $507, $894 or $1548, each beside a struck-through $249, $229 or $209, and tirzepatide $229, $209 or $199 a month, billed $687, $1254 or $2388, beside a struck-through $339, $319 or $299. Oral semaglutide costs $179 a month month to month, microdose plans $149 a month, sermorelin from $199 and NAD+ from $239 for 4 weeks, and Ozempic and Zepbound pens $1,229 and $1,399 a month. The product pages instead give ranges, such as $200 to $550 a month for semaglutide and $250 to $1,400 for tirzepatide.Source: Medsol RX's packages page; Medsol RX's semaglutide page; Medsol RX's tirzepatide page.
S8PASSNo FDA warning letter names Medsol RX or reviews its website, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injections, compounded tirzepatide injections, compounded oral semaglutide, tirzepatide orally disintegrating tablets, GLP-1 microdose plans, Ozempic, Zepbound, sermorelin, NAD+, B12 MIC injections, glutathione, L-carnitine, Lipo-C, methylene blue.

Visit Medsol RX

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.